Suppr超能文献

严重急性呼吸综合征(SARS)冠状病毒诱导的肺上皮细胞因子通过调节单核细胞衍生的巨噬细胞和树突状细胞的内在功能,加剧了SARS的发病机制。

Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells.

作者信息

Yoshikawa Tomoki, Hill Terence, Li Kui, Peters Clarence J, Tseng Chien-Te K

机构信息

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555-0609, USA.

出版信息

J Virol. 2009 Apr;83(7):3039-48. doi: 10.1128/JVI.01792-08. Epub 2008 Nov 12.

Abstract

Severe acute respiratory syndrome (SARS), which is caused by a novel coronavirus (CoV), is a highly communicable disease with the lungs as the major pathological target. Although SARS likely stems from overexuberant host inflammatory responses, the exact mechanism leading to the detrimental outcome in patients remains unknown. Pulmonary macrophages (Mphi), airway epithelium, and dendritic cells (DC) are key cellular elements of the host innate defenses against respiratory infections. While pulmonary Mphi are situated at the luminal epithelial surface, DC reside abundantly underneath the epithelium. Such strategic locations of these cells within the airways make it relevant to investigate their likely impact on SARS pathogenesis subsequent to their interaction with infected lung epithelial cells. To study this, we established highly polarized human lung epithelial Calu-3 cells by using the Transwell culture system. Here we report that supernatants harvested from the apical and basolateral domains of infected Calu-3 cells are potent in modulating the intrinsic functions of Mphi and DC, respectively. They prompted the production of cytokines by both Mphi and DC and selectively induced CD40 and CD86 expression only on DC. However, they compromised the abilities of the DC and Mphi in priming naïve T cells and phagocytosis, respectively. We also identified interleukin-6 (IL-6) and IL-8 as key SARS-CoV-induced epithelial cytokines capable of inhibiting the T-cell-priming ability of DC. Taken together, our results provide insights into the molecular and cellular bases of the host antiviral innate immunity within the lungs that eventually lead to an exacerbated inflammatory cascades and severe tissue damage in SARS patients.

摘要

严重急性呼吸综合征(SARS)由一种新型冠状病毒(CoV)引起,是一种以肺部为主要病理靶点的高度传染性疾病。尽管SARS可能源于宿主过度活跃的炎症反应,但导致患者出现不良后果的确切机制仍不清楚。肺巨噬细胞(Mphi)、气道上皮细胞和树突状细胞(DC)是宿主针对呼吸道感染的固有防御的关键细胞成分。肺Mphi位于管腔上皮表面,而DC大量存在于上皮下方。这些细胞在气道内的这种战略位置使得研究它们与受感染的肺上皮细胞相互作用后对SARS发病机制可能产生的影响具有重要意义。为了研究这一点,我们使用Transwell培养系统建立了高度极化的人肺上皮Calu-3细胞。在此我们报告,从受感染的Calu-3细胞的顶端和基底外侧区域收获的上清液分别对调节Mphi和DC的固有功能具有强大作用。它们促使Mphi和DC都产生细胞因子,并仅在DC上选择性诱导CD40和CD86表达。然而,它们分别损害了DC启动幼稚T细胞的能力和Mphi的吞噬能力。我们还确定白细胞介素-6(IL-6)和IL-8是关键的SARS-CoV诱导的上皮细胞因子,能够抑制DC启动T细胞的能力。综上所述,我们的结果为肺部宿主抗病毒固有免疫的分子和细胞基础提供了见解,这些基础最终导致SARS患者炎症级联反应加剧和严重的组织损伤。

相似文献

4
SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
Virus Res. 2008 Apr;133(1):33-44. doi: 10.1016/j.virusres.2007.03.013. Epub 2007 Apr 23.
5
Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro.
J Virol. 2006 Mar;80(6):2684-93. doi: 10.1128/JVI.80.6.2684-2693.2006.

引用本文的文献

1
Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development.
Front Immunol. 2025 Mar 13;16:1538301. doi: 10.3389/fimmu.2025.1538301. eCollection 2025.
2
Progress on diagnosis and treatment of multisystem inflammatory syndrome in children.
Front Immunol. 2025 Feb 19;16:1551122. doi: 10.3389/fimmu.2025.1551122. eCollection 2025.
3
Severe acute respiratory syndrome coronavirus 2 infection unevenly impacts metabolism in the coronal periphery of the lungs.
iScience. 2025 Jan 2;28(2):111727. doi: 10.1016/j.isci.2024.111727. eCollection 2025 Feb 21.
4
Regulatory role of microRNAs in virus-mediated inflammation.
J Inflamm (Lond). 2024 Nov 4;21(1):43. doi: 10.1186/s12950-024-00417-7.
5
COVID-19-Induced Rheumatoid Arthritis: Case Series and Systematic Review of the Literature.
Mediterr J Rheumatol. 2024 May 21;35(2):291-297. doi: 10.31138/mjr.171223.cir. eCollection 2024 Jun.
7
Recombinant ACE2 - Opportunities and Challenges in COVID-19 Treatment.
Infect Disord Drug Targets. 2025;25(1):e180424229061. doi: 10.2174/0118715265298816240321045741.
8
The Therapy of SARS-CoV-2 Infection in Children.
J Clin Med. 2023 Dec 25;13(1):120. doi: 10.3390/jcm13010120.
9
Post-COVID-19 Illness Trend in a Local Community in Bangladesh.
Cureus. 2023 Sep 26;15(9):e45998. doi: 10.7759/cureus.45998. eCollection 2023 Sep.
10
What are the current anti-COVID-19 drugs? From traditional to smart molecular mechanisms.
Virol J. 2023 Oct 24;20(1):241. doi: 10.1186/s12985-023-02210-z.

本文引用的文献

1
Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment.
Clin Exp Allergy. 2008 Mar;38(3):466-72. doi: 10.1111/j.1365-2222.2007.02906.x.
2
SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
Virus Res. 2008 Apr;133(1):33-44. doi: 10.1016/j.virusres.2007.03.013. Epub 2007 Apr 23.
3
SARS coronavirus and innate immunity.
Virus Res. 2008 Apr;133(1):101-12. doi: 10.1016/j.virusres.2007.03.015. Epub 2007 Apr 23.
5
GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.
J Virol. 2007 Jan;81(2):964-76. doi: 10.1128/JVI.02076-06. Epub 2006 Nov 8.
8
How the SARS coronavirus causes disease: host or organism?
J Pathol. 2006 Jan;208(2):142-51. doi: 10.1002/path.1897.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验